Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 70,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 70,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 57,478 | 78,781 | 86,460 | 92,828 | 126,872 |
| Operating Income | 12,522 | -78,781 | -86,460 | -92,828 | -126,872 |
| Other Income | 9,845 | 9,105 | 4,018 | 1,659 | 1,276 |
| Pre-tax Income | 22,367 | -69,676 | -82,442 | -91,169 | -125,596 |
| Net Income Continuous | 22,367 | -69,676 | -82,442 | -91,169 | -125,596 |
| Net Income | $22,367 | $-69,676 | $-82,442 | $-91,169 | $-125,596 |
| EPS Basic Total Ops | 0.39 | -1.27 | -1.88 | -2.52 | -3.47 |
| EPS Basic Continuous Ops | 0.39 | -1.27 | -1.88 | -2.51 | -3.47 |
| EPS Diluted Total Ops | 0.39 | -1.27 | -1.88 | -2.52 | -3.47 |
| EPS Diluted Continuous Ops | 0.39 | -1.27 | -1.88 | -2.51 | -3.47 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.27 | -1.88 | -2.52 | -3.47 |
| EBITDA(a) | $12,847 | $-78,438 | $-86,023 | $-92,320 | $-126,667 |